Lexaria Bioscience Corp (LEXX)
3.475
+0.38
(+12.46%)
USD |
NASDAQ |
May 01, 16:00
3.475
0.00 (0.00%)
After-Hours: 19:08
Lexaria Bioscience Price to Book Value: 6.867 for May 1, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 30, 2024 | 6.106 |
| April 29, 2024 | 4.861 |
| April 26, 2024 | 4.644 |
| April 25, 2024 | 4.328 |
| April 24, 2024 | 4.347 |
| April 23, 2024 | 4.426 |
| April 22, 2024 | 4.476 |
| April 19, 2024 | 4.347 |
| April 18, 2024 | 4.446 |
| April 17, 2024 | 4.624 |
| April 16, 2024 | 4.565 |
| April 15, 2024 | 3.932 |
| April 12, 2024 | 4.189 |
| April 11, 2024 | 4.96 |
| April 10, 2024 | 5.256 |
| April 09, 2024 | 5.336 |
| April 08, 2024 | 5.752 |
| April 05, 2024 | 5.927 |
| April 04, 2024 | 6.199 |
| April 03, 2024 | 6.626 |
| April 02, 2024 | 6.743 |
| April 01, 2024 | 6.646 |
| March 28, 2024 | 7.054 |
| March 27, 2024 | 7.209 |
| March 26, 2024 | 7.365 |
| Date | Value |
|---|---|
| March 25, 2024 | 7.676 |
| March 22, 2024 | 6.743 |
| March 21, 2024 | 6.684 |
| March 20, 2024 | 7.190 |
| March 19, 2024 | 7.773 |
| March 18, 2024 | 6.607 |
| March 15, 2024 | 7.578 |
| March 14, 2024 | 7.481 |
| March 13, 2024 | 8.550 |
| March 12, 2024 | 8.122 |
| March 11, 2024 | 11.87 |
| March 08, 2024 | 10.45 |
| March 07, 2024 | 9.499 |
| March 06, 2024 | 8.511 |
| March 05, 2024 | 6.421 |
| March 04, 2024 | 5.699 |
| March 01, 2024 | 5.547 |
| February 29, 2024 | 6.554 |
| February 28, 2024 | 8.434 |
| February 27, 2024 | 7.938 |
| February 26, 2024 | 7.475 |
| February 23, 2024 | 7.209 |
| February 22, 2024 | 7.405 |
| February 21, 2024 | 7.340 |
| February 20, 2024 | 7.568 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.9326
Minimum
May 10 2023
29.34
Maximum
May 10 2019
7.093
Average
3.388
Median
Price to Book Value Benchmarks
| Aurinia Pharmaceuticals Inc | 1.972 |
| Sunshine Biopharma Inc | 0.0403 |
| Acasti Pharma Inc | 0.4200 |
| Edesa Biotech Inc | 2.409 |
| Xenon Pharmaceuticals Inc | 3.457 |
Price to Book Value Related Metrics
| PS Ratio | 77.35 |
| Price | 3.475 |
| Earnings Yield | -19.57% |
| Market Cap | 44.78M |